Vallon Pharmaceuticals, Inc. – NASDAQ:VLON

Market open

Closed in about 3 hours

+10.62%

year

Market Cap	N/A
Enterprise value	N/A

P/E	-0.66
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	1.78
PEG ratio	-0.01
EPS	N/A

Revenue	N/A
EBITDA	-13.22M
Income	-12.49M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON): Profit margin
Jun 2023	0	-6.74M
Sep 2023	0	-2.13M
Dec 2023	0	-1.72M
Mar 2024	0	-1.88M

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON): Debt to assets
Jun 2023	5642000	1.60M	28.43%
Sep 2023	4404000	2.17M	49.43%
Dec 2023	2956000	2.69M	91.24%
Mar 2024	4587000	1.78M	39%

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON): Cash Flow
Mar 2023	-2.31M	0	-23K
Sep 2023	-2.13M	0	0
Dec 2023	5.81M	-428K	10.82M
Mar 2024	0	0	4.48M

Vallon Pharmaceuticals alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Vallon Pharmaceuticals
Employees

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON): Employee count
Aug 2023	2
Sep 2023	2
Oct 2023	2
Nov 2023	2
Dec 2023	2
Jan 2024	2
Feb 2024	2
Mar 2024	2
Apr 2024	2
May 2024	2
Jun 2024	2
Jul 2024	2

Vallon Pharmaceuticals
Insider Trading

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON): Insider trades (number of shares)
Period	Buy	Sel
Feb 2021	1000	0
May 2021	17500	0
Jun 2021	6250	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	4 Jun 2021	KELLY LEANNE M. officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock	1,508	$4.08	$6,153
Purchase	3 Jun 2021	KELLY LEANNE M.	Common Stock	1,085	$4.05	$4,394
Purchase	2 Jun 2021	KELLY LEANNE M.	Common Stock	3,657	$4	$14,628
Purchase	26 May 2021	PAYNE JOSEPH E	Common Stock	6,800	$4.5	$30,600
Purchase	25 May 2021	PAYNE JOSEPH E	Common Stock	10,700	$3.85	$41,195
Purchase	12 Feb 2021	BAKER DAVID CHARLES director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	1,000	N/A	N/A

VLON insider trading transactions

Vallon Pharmaceuticals
Patents

Status	Patent	Filling date	Issue date
Application	Application ABUSE DETERRENT FORMULATIONS OF AMPHETAMINE Filling date: 11 Nov 2019 Issue date: 19 Mar 2020	11 Nov 2019	19 Mar 2020

VLON patents

Vallon Pharmaceuticals
Executives

Insider	Age	Since	Compensation
Mr. David C. Baker (1963) Chief Executive Officer, Pres & Director	62		$339,900
Ms. Penny S. Toren (1967) Senior Vice President of Regulatory Affairs & Program Management	58		$242,050

Vallon Pharmaceuticals
Latest News

Monday, 6 March 2023
15:07	Best Penny Stocks For 2023? 3 To Watch In March	PennyStocks
Tuesday, 14 February 2023
06:00	How to Analyze Penny Stocks for Profits	PennyStocks
Monday, 13 February 2023
08:22	Why Is Vallon Pharmaceuticals (VLON) Stock Up 38% Today	InvestorPlace
Saturday, 11 February 2023
11:00	The Benefits of Investing in Penny Stocks in the Long Term	PennyStocks
Friday, 10 February 2023
10:45	3 Penny Stocks To Watch After Big News In February 2023	PennyStocks
Wednesday, 11 January 2023
08:45	Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event	GlobeNewsWire
Thursday, 15 December 2022
06:00	Making Profits With Penny Stocks, Beginners Guide	PennyStocks
Wednesday, 14 December 2022
10:45	Why Is Vallon Pharmaceuticals (VLON) Stock Up 95% Today?	InvestorPlace
Wednesday, 19 October 2022
11:50	Best Penny Stocks To Buy Now? 4 Low Float Stocks To Watch This Week	PennyStocks
Sunday, 3 July 2022
11:30	How to Make a Penny Stocks Watchlist in July 2022	PennyStocks
Tuesday, 28 June 2022
20:25	Trending Penny Stocks For Your Watchlist Next Month	PennyStocks
12:30	Best Penny Stocks For July 2022? 5 To Watch Right Now	PennyStocks
Friday, 22 April 2022
11:22	Why Is Vallon Pharmaceuticals (VLON) Stock Up 90%+ Today?	InvestorPlace
10:11	Vallon Pharmaceuticals stock is the biggest gainer and most active after exploring possible sale	Market Watch
09:32	Best Penny Stocks to Buy Now? 3 Climbing in Premarket Trading	PennyStocks
Tuesday, 22 March 2022
10:32	Vallon (VLON) Plummets as ADAIR Study Misses Primary Goal	Zacks Investment Research
Thursday, 20 January 2022
08:35	Vallon Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference	GlobeNewsWire
Tuesday, 4 January 2022
08:05	Vallon Pharmaceuticals to Present at the H.C. Wainwright BioConnect Conference	GlobeNewsWire
Tuesday, 23 November 2021
14:30	Best Penny Stocks To Buy Now? 5 To Watch Before Next Week	PennyStocks
Thursday, 11 November 2021
08:05	Vallon Pharmaceuticals to Present at the Virtual Investor Roundtable Event	GlobeNewsWire
Wednesday, 10 November 2021
08:35	Vallon Pharmaceuticals to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference	GlobeNewsWire
Tuesday, 12 October 2021
08:35	Vallon Pharmaceuticals Provides Update on Recent Pipeline and Corporate Advancements	GlobeNewsWire
Tuesday, 14 September 2021
08:05	Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board	GlobeNewsWire

Frequently Asked Questions (FAQ)

When is Vallon Pharmaceuticals's next earnings date?

Unfortunately, Vallon Pharmaceuticals's (VLON) next earnings date is currently unknown.
Does Vallon Pharmaceuticals pay dividends?

No, Vallon Pharmaceuticals does not pay dividends.
What is Vallon Pharmaceuticals's stock symbol?

Vallon Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "VLON".
What is Vallon Pharmaceuticals's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Vallon Pharmaceuticals?

Shares of Vallon Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Vallon Pharmaceuticals's key executives?
Vallon Pharmaceuticals's management team includes the following people:
- Mr. David C. Baker Chief Executive Officer, Pres & Director(age: 62, pay: $339,900)
- Ms. Penny S. Toren Senior Vice President of Regulatory Affairs & Program Management(age: 58, pay: $242,050)
How many employees does Vallon Pharmaceuticals have?

As Jul 2024, Vallon Pharmaceuticals employs 2 workers.
When Vallon Pharmaceuticals went public?

Vallon Pharmaceuticals, Inc. is publicly traded company for more then 4 years since IPO on 10 Feb 2021.
What is Vallon Pharmaceuticals's official website?

The official website for Vallon Pharmaceuticals is vallon-pharma.com.
Where are Vallon Pharmaceuticals's headquarters?

Vallon Pharmaceuticals is headquartered at Two Logan Square, Philadelphia, PA.
How can i contact Vallon Pharmaceuticals?

Vallon Pharmaceuticals's mailing address is Two Logan Square, Philadelphia, PA and company can be reached via phone at +267 607 8255.

Vallon Pharmaceuticals, Inc.

vallon-pharma.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

+267 607 8255

Two Logan Square
Philadelphia, PA 19103

CIK: 0001824293
ISIN: US92023M1018
CUSIP: 92023M101